Koers China Resources Pharmaceutical Group Limited
Aandelen
3320
HK0000311099
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,78 HKD | +0,52% | -2,69% | +12,67% |
Omzet 2024 * | 289 mld. 37,02 mld. 34,04 mld. | Omzet 2025 * | 320 mld. 41,02 mld. 37,72 mld. | Marktkapitalisatie | 36,12 mld. 4,63 mld. 4,25 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 4,67 mld. 598 mln. 550 mln. | Nettowinst (verlies) 2025 * | 5,23 mld. 670 mln. 616 mln. | EV/omzet 2024 * | 0,24 x |
Nettoschuld 2024 * | 33,07 mld. 4,23 mld. 3,89 mld. | Nettoschuld 2025 * | 31,59 mld. 4,05 mld. 3,72 mld. | EV/omzet 2025 * | 0,21 x |
K/w-verhouding 2024 * |
7,83
x | K/w-verhouding 2025 * |
6,96
x | Werknemers | 72.986 |
Dividendrendement 2024 * |
2,92% | Dividendrendement 2025 * |
3,27% | Vrij verhandelbaar | 27,95% |
1 dag | +0,52% | ||
1 week | -2,69% | ||
Lopende maand | -0,17% | ||
1 maand | +8,65% | ||
3 maanden | +11,37% | ||
6 maanden | +21,68% | ||
Lopend jaar | +12,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Song Bai
CEO | Chief Executive Officer | 52 | 14-01-22 |
Rong Hui Deng
DFI | Director of Finance/CFO | 46 | 13-06-23 |
Yue Wei Han
CHM | Chairman | 56 | 22-10-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rui Fang Jiao
BRD | Director/Board Member | 47 | 14-01-22 |
Ting Mei Fu
BRD | Director/Board Member | 57 | 01-06-16 |
Ke Jian Zhang
BRD | Director/Board Member | 68 | 20-06-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.92% | 4 M€ | -27,92% | ||
0.52% | 2 M€ | -17,32% | - | |
0.12% | 4 M€ | -11,56% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
05-06-24 | 5,78 | +0,52% | 6 516 000 |
04-06-24 | 5,75 | -0,52% | 7 065 607 |
03-06-24 | 5,78 | -0,17% | 11 937 510 |
31-05-24 | 5,79 | -1,70% | 25 020 030 |
30-05-24 | 5,89 | -0,84% | 4 632 332 |
uitgestelde koers Hong Kong S.E., 05 juni 2024 om 10:08 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,67% | 4,62 mld. | |
+42,83% | 750 mld. | |
+34,11% | 606 mld. | |
-5,70% | 356 mld. | |
+18,06% | 326 mld. | |
+4,63% | 286 mld. | |
+17,68% | 246 mld. | |
+10,77% | 213 mld. | |
-3,07% | 213 mld. | |
+2,43% | 167 mld. |